Professor of Pediatrics, University Pennsylvania
Pediatric Hematology & Oncology
Dr. Beverly J. Lange, MD
|
|
Give Review
Beverly J. Lange works in the field of Pediatric Hematology & Oncology. She went to medical school at Temple University School of Medicine. She received awards:"Fellow (FAAP)" and "Super Doctor". Beverly Lange is also a published physician. She has 49 publication published. The most recent publication is: Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncolog...
Publications
- Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncolog...
- Proactive enteral tube feeding in pediatric patients undergoing chemotherapy.
- Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: A Report from the Children's Oncology Group.
- Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation.
- FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report.
- Germline genetic variation and treatment response on CCG-1891.
- Estimation of the prevalence of Fanconi anemia among patients with de novo acute myelogenous leukemia who have poor recovery from chemotherapy.
- Soluble interleukin-2 receptor ? activation in a Children's Oncology Group randomized trial of interleukin-2 Therapy for Pediatric Acute Myeloid Leukemia.
- Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: A report from the Children's Oncology Group.
- Individual patient data meta-analysis of randomized trials evaluating interleukin-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.
- Ya gotta have heart.
- The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.
- Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo ...
- T(11q23): brand necessary.
- Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
- FAS promoter polymorphism: outcome of childhood acute myeloid leukemia. A children's oncology group report.
- Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology Group.
- Structural and numerical variation of FLT3/ITD in pediatric AML.
- Central nervous system juvenile xanthogranuloma with malignant transformation.
- Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.
- Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213.
- Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia.
- Infections with viridans group streptococci in children with cancer.
- Obesity and outcome in pediatric acute lymphoblastic leukemia.
- Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CC...
- Clinical implications of FLT3 mutations in pediatric AML.
- FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia.
- Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.
- Obesity in pediatric oncology.
- Mortality in overweight and underweight children with acute myeloid leukemia.
- Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapy.
- Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance ...
- Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941.
- Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group.
- Identifying psychosocial risk indicative of subsequent resource use in families of newly diagnosed pediatric oncology patients.
- Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute mye...
- Strength and functional mobility in children with acute lymphoblastic leukemia.
- Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children.
- Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: a report from the Children's Cancer Group.
- Long-term (15 years) outcome in an infant with metastatic adrenocortical carcinoma.
- Evolving concepts of management of febrile Neutropenia in children with cancer.
- Factitious fungus in two children with cancer receiving liposomal amphotericin.
- Isolated extramedullary relapse in acute myeloid leukemia: A retrospective analysis.
- Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of M...
- A pharmacoeconomic analysis of pegaspargase versus native Escherichia coli L-asparaginase for the treatment of children with standard-risk, acute lymphoblastic leukemi...
- Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia.
- Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group.
- Pediatric Acute Lymphoblastic Leukemia: Challenges and Controversies in 2000.
Schools
Temple University
Philadelphia General Hospital
Precept Dr Wernec Henle
Precept Dr Audrey Evans
Conditions Treated
- Myeloproliferative Disorders
- Neutropenia
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Fellow (FAAP)
- Super Doctor
Education
-
Children's Hospital of Philadelphia -
Temple University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Shannon L. Maude, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristina A. Cole, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stella T. Chou, MD
This Doctor is OpenDoctor Recommended.
|